217 filings
Page 2 of 11
8-K
j24mhd7wnywsq3vwvg
14 Apr 23
Other Events
12:38pm
8-K
fx7nd
13 Mar 23
Other Events
7:13am
8-K
kdhpex
10 Mar 23
Departure of Directors or Certain Officers
5:30pm
8-K
ov3ezydt3o2ctwpe
6 Mar 23
Departure of Directors or Certain Officers
7:15am
8-K
dvc2sg
28 Feb 23
Ocugen Provides Business Update with Fourth Quarter and Full Year 2022 Financial Results
7:38am
8-K
onsxvwd
6 Feb 23
Other Events
7:32am
8-K
rigdtbt
9 Jan 23
Other Events
6:59am
8-K
atkfbo22q3bjy qlaxac
9 Jan 23
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3
6:55am
8-K
hv41tvt5kuxrcugvn987
16 Dec 22
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
6:41am
8-K
oc75p ze8
8 Nov 22
Other Events
9:12am
8-K
f1o256k
8 Nov 22
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
7:37am
8-K
nlrqc2x hz
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
csmjk rwatlc6lccvx
28 Sep 22
Entry into a Material Definitive Agreement
6:47am
8-K
h9pp8cuo0p
14 Sep 22
Ocugen Announces Publication of a Comprehensive Review of BBV152 In Frontiers In Immunology
4:05pm
8-K
8d0gbji
26 Aug 22
Other Events
5:04pm
8-K
2k3r1r17 0pbfl
17 Aug 22
Other Events
4:03pm
8-K
sb478kj5i5uvg5l wty
16 Aug 22
Other Events
4:09pm
8-K
6i3y 9h3s9bkb
5 Aug 22
Ocugen Provides Business Update & Second Quarter 2022 Financial Results
7:35am
8-K
kvo8w
10 Jun 22
Entry into a Material Definitive Agreement
4:37pm
8-K
7xo0rg11fog h02z0pz
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:12pm